Did Praxis Precision Medicines, Inc. (PRAX) Mislead Investors? Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results […]